Trends in Osteoporosis Drug Therapy Receipt Among Commercial and Medicare Advantage Enrollees in the United States, 2011-2022 - Quiz - MDSpire

Trends in Osteoporosis Drug Therapy Receipt Among Commercial and Medicare Advantage Enrollees in the United States, 2011-2022

  • By

  • Alexander O Everhart

  • Juan P Brito

  • Bart L Clarke

  • Jeph Herrin

  • Pinar Karaca-Mandic

  • Kurt A Kennel

  • Nehu Parimi

  • Clifford J Rosen

  • Mark Takagi

  • Rozalina G McCoy

  • January 15, 2025

  • 0 min

Share

Original Source(s)

Trends in Osteoporosis Drug Therapy Receipt Among Commercial and Medicare Advantage Enrollees in the United States, 2011-2022

  • by Alexander O Everhart, Juan P Brito, Bart L Clarke, Jeph Herrin, Pinar Karaca-Mandic, Kurt A Kennel, Nehu Parimi, Clifford J Rosen, Mark Takagi, Rozalina G McCoy

  • January 15, 2025

Related Content

Zoledronate Administration Lowers Vertebral Fracture Incidence in Younger Postmenopausal Women Lacking Osteoporosis

Defining orthoplastic limb salvage centers: a systematic review

Gut microbiota orchestrates bone homeostasis: a multi-pathway network from intestine to skeleton